Skip to main content
PharmSpace

Antiplatelet agents · Cardiovascular

Aspirin (acetylsalicylic acid)

ASA · acetylsalicylic acid · Aspirin® · Entrophen®(brand names vary by market)

One irreversible acetylation, and the platelet never recovers.

Illustration of Aspirin (acetylsalicylic acid) as a tabletASP

Also: modified release, suppository

Mechanism

Irreversibly acetylates cyclooxygenase-1 in the platelet, abolishing thromboxane A2 production for the platelet's entire life. Platelets have no nucleus and cannot make more enzyme, which is why a low daily dose achieves total inhibition.

Indications

  • Secondary prevention after myocardial infarction or ischemic stroke
  • Acute coronary syndrome
  • After coronary stenting
  • Peripheral arterial disease

Formulations

TabletModified releaseSuppository

Dosing concepts

Antiplatelet versus analgesic dose

The antiplatelet dose is a small fraction of the analgesic one. Higher doses add gastrointestinal toxicity without adding antiplatelet effect, because COX-1 inhibition is already complete.

Acute chest pain

Chewed rather than swallowed, because dissolution rather than absorption is what limits the speed of onset.

Concepts, not prescribing instructions. Practice numbers live in current references and local protocols.

Pharmacokinetics

Bioavailability
~50 to 70%, lower for enteric-coated products
Half-life
Aspirin itself 15 to 20 min; the platelet effect lasts 7 to 10 days
Elimination
hepatic: Rapidly hydrolysed to salicylate; the antiplatelet effect long outlives the drug
Play with these concepts in the PK Lab

Adverse effects

  • Gastrointestinal bleeding and ulcerationcommon & serious
  • Dyspepsiacommon
  • Bruising and prolonged bleedingcommon
  • Bronchospasm in aspirin-exacerbated respiratory diseaseserious
  • Reye syndrome in children with viral illnessserious

Contraindications & precautions

Contraindications

  • Active peptic ulceration or bleeding
  • Aspirin-exacerbated respiratory disease
  • Children under 16 with a febrile illness
  • Severe hepatic or renal impairment

Precautions

  • Prior gastrointestinal bleeding
  • Concurrent anticoagulation or NSAIDs
  • Uncontrolled hypertension
  • Gout: it raises urate at low doses

Interactions

Monitoring

Dyspepsia and bleeding symptoms

The main harm, and largely preventable

Hemoglobin in anyone at risk

Chronic occult loss

Whether the indication still exists

Primary-prevention aspirin has largely been withdrawn from guidance

Counselling points

  • Take it with food.
  • Tell us about indigestion or black stools rather than treating it yourself.
  • Do not add ibuprofen or naproxen without asking; the combination multiplies stomach risk and ibuprofen can block aspirin's effect.
  • Keep taking it before dental work unless specifically told otherwise.

Clinical pearls

  • Ibuprofen taken shortly before aspirin occupies the COX-1 site reversibly and blocks the irreversible acetylation. In a patient who takes both, timing genuinely matters and aspirin should come first.
  • Enteric coating reduces dyspepsia but not the bleeding risk, because that risk is systemic prostaglandin inhibition rather than local contact.
  • For primary prevention in someone who has never had an event, the modern evidence puts net benefit near zero. Finding it on a list is a deprescribing conversation.

References & review

  • Acetylsalicylic acid product monograph (consult the current version for your market) (monograph)
  • Goodman & Gilman's The Pharmacological Basis of Therapeutics, 14th ed. (reference-work)

Last reviewed 2026-08-16 · jurisdiction: global · drug information changes; verify against current references before practice use.